{"gene":"ATP7B","run_date":"2026-06-09T22:02:44","timeline":{"discoveries":[{"year":2022,"finding":"Cryo-EM structure of frog ATP7B in a copper-free (E2-Pi) state revealed: a ring of negatively charged residues lines the cytoplasmic copper entrance gated by a conserved basic residue; a network of copper-coordinating ligands in the transmembrane domain delineates a stepwise copper transport pathway; the N-terminal metal-binding domains interact with both the A and P cytoplasmic domains, poised to exert copper-dependent regulation of ATP hydrolysis coupled to transmembrane copper transport.","method":"Cryo-electron microscopy structure determination","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with functional domain mapping; single study but Tier 1 method with detailed structural-functional analysis","pmids":["35245129"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structures of human ATP7B in the E1 state (apo, putative copper-bound, and putative cisplatin-bound forms) showed that the sixth N-terminal metal-binding domain (MBD6) binds at the cytoplasmic copper entry site of the transmembrane domain (TMD), facilitating copper delivery from MBD6 to the TMD; sulfur-containing residues in the TMD mark the copper transport pathway; comparison with E2-Pi frog ATP7B structure supports an ATP-driven copper transport model.","method":"Cryo-electron microscopy structure determination (multiple states)","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structures in three distinct states, human protein, single study with multiple orthogonal structural comparisons","pmids":["37074913"],"is_preprint":false},{"year":2014,"finding":"In response to elevated copper, ATP7B moves from the Golgi to lysosomes, imports copper into their lumen, and then enables lysosomal exocytosis through interaction with the p62 subunit of dynactin, allowing lysosome translocation toward the canalicular pole of hepatocytes for copper excretion into bile.","method":"Live-cell fluorescence microscopy, Co-IP (ATP7B–p62/dynactin), siRNA knockdown, copper accumulation/excretion assays in HepG2 cells and primary hepatocytes","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal interaction studies, functional copper-excretion assays, RNAi rescue, multiple orthogonal methods in single rigorous study","pmids":["24909901"],"is_preprint":false},{"year":2006,"finding":"ATP7B mediates vesicular sequestration of excess intracellular copper rather than direct translocation across the canalicular membrane; elevated copper stimulates ATP7B trafficking to pericanalicular vesicles in HepG2 cells; mutation of an endocytic retrieval signal causes constitutive vesicular localization; wild-type and mutant ATP7B cause CHO cells to accumulate copper in vesicles that subsequently undergo exocytosis.","method":"Immunofluorescence microscopy, copper accumulation assays in CHO cells expressing wild-type and endocytic-signal mutant ATP7B, site-directed mutagenesis","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct localization experiments with functional consequence, mutagenesis, and copper transport assays; multiple orthogonal methods in one study","pmids":["16472602"],"is_preprint":false},{"year":1998,"finding":"Introduction of WND (ATP7B) cDNA via recombinant adenovirus into LEC rats (Wilson disease model) restored ATP7B protein to the Golgi apparatus and rescued synthesis of holoceruloplasmin (oxidase-active, copper-bound ceruloplasmin) in plasma, directly demonstrating that ATP7B functions in copper transport coupled with ceruloplasmin biosynthesis and that the Golgi is the functional site.","method":"Adenovirus-mediated gene delivery, immunofluorescence and subcellular fractionation, Western blot and plasma ceruloplasmin oxidase activity measurement in LEC rats","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo functional rescue with multiple biochemical readouts, replicated across multiple independent measurements in a well-established disease model","pmids":["9430732"],"is_preprint":false},{"year":1998,"finding":"The conserved CPC (Cys-Pro-Cys) motif in the membrane-spanning segment of ATP7B is essential for copper transport; mutation of CPC to SPS abolished ATP7B function in yeast complementation of ccc2 mutants. Five Wilson disease missense mutations in predicted membrane-spanning segments retained partial copper transport activity in yeast.","method":"Yeast complementation assay (ccc2 mutant rescue), site-directed mutagenesis of ATP7B cDNA","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro functional reconstitution (yeast complementation) with systematic mutagenesis; multiple variants tested, clear mechanistic conclusion","pmids":["9837819"],"is_preprint":false},{"year":2000,"finding":"Wilson disease ATP7B variant proteins that retain copper transport activity in yeast (Asp765Asn, Leu776Val) showed mislocalization in CHO cells and impaired copper-dependent redistribution; the CPC→SPS mutant and Gly943Ser localized normally to the Golgi but could not redistribute in response to copper, indicating that copper-induced trafficking is a distinct functional requirement from catalytic copper transport.","method":"Yeast complementation assay, transient transfection of CHO cells, triple-label immunofluorescence microscopy","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional assay combined with direct localization in mammalian cells; multiple variants systematically analyzed","pmids":["10942420"],"is_preprint":false},{"year":2007,"finding":"COMMD1 specifically interacts with the amino-terminal region of ATP7B independently of intracellular copper levels and ATOX1 expression. Four Wilson disease patient-derived N-terminal mutations significantly increased ATP7B binding to COMMD1, leading to mislocalization and increased degradation of ATP7B. COMMD1 markedly decreases the stability of newly synthesized ATP7B but does not affect copper-induced trafficking.","method":"GST pull-down, co-immunoprecipitation, immunofluorescence microscopy, site-directed mutagenesis, biosynthetic pulse-chase labeling","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal pull-down and Co-IP with mutagenesis and pulse-chase; multiple orthogonal methods in single study","pmids":["17919502"],"is_preprint":false},{"year":2011,"finding":"Clusterin and COMMD1 independently interact with ATP7B and facilitate its degradation via distinct pathways: clusterin via the lysosomal pathway and COMMD1 via the proteasomal pathway. The clusterin–ATP7B interaction is enhanced by oxidative stress or ATP7B mutation; COMMD1–ATP7B interaction increases only with misfolding mutations. Endogenous ATP7B exists in a complex with both clusterin and COMMD1 simultaneously, but these interactions are neither competitive nor cooperative.","method":"Co-immunoprecipitation, overexpression and siRNA knockdown, Western blot for endogenous protein levels, lysosomal and proteasomal inhibitor experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal Co-IP, gain- and loss-of-function, pathway inhibitors; multiple orthogonal methods in single study","pmids":["22130675"],"is_preprint":false},{"year":2010,"finding":"Protein kinase D (PKD) phosphorylates serine residues of ATP7B at the trans-Golgi network; this phosphorylation protects ATP7B from proteasome-mediated degradation and is required for its trafficking from the Golgi to cytosolic vesicles. Both PKD-mediated phosphorylation and subsequent trafficking are copper-dependent: mutations of critical copper-binding sites completely prevented both. Mutation of Ser-478/481/1121/1453 to Ala markedly reduced ATP7B trafficking.","method":"Microsomal phosphorylation assays with PKD inhibitor CID755673, Western blot, site-directed mutagenesis, confocal microscopy in COS-1 and HepG2 cells, proteasome inhibitor (MG132) experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro phosphorylation assay, pharmacological and genetic perturbation, mutagenesis with functional readout; multiple orthogonal methods","pmids":["21189263"],"is_preprint":false},{"year":2019,"finding":"Copper relay through the N-terminal metal-binding domains (MBDs) of ATP7B follows a defined mechanistic model: MBD1-3 form a regulatory unit; copper delivery via Atox1 to this unit and loading of MBD3 promotes release of inhibitory interactions; MBD4 can be mutated without large effect; intact copper sites in MBD5 or MBD6 are required for copper transport; only MBD6 can deliver copper to truncated ATP7B lacking all six MBDs, suggesting a specific docking role for MBD6.","method":"Yeast copper transport assay with strategic cysteine-to-serine mutations blocking individual MBD copper-binding sites in full-length and truncated ATP7B constructs","journal":"Metallomics : integrated biometal science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic in vivo functional reconstitution with multiple designed mutants; single lab but extensive mutagenesis series with clear mechanistic conclusions","pmids":["31321400"],"is_preprint":false},{"year":2017,"finding":"Human ATP7B forms stable dimers in eukaryotic cells; the dimer interface is formed by conserved domains (not the N-terminal MBDs 1–4, which are unique to human ATP7B). Dimeric structure is retained during trafficking between intracellular compartments. A low-resolution 3D model by negative-stain EM of purified dimeric 1-4ΔMBD-7B provided the first structural insight into the overall architecture of a human Cu-ATPase.","method":"Co-immunoprecipitation of differentially tagged variants, purification of ATP7B after membrane solubilization, negative-stain electron microscopy, single-particle analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP with differentially tagged constructs plus low-resolution EM; single lab, two orthogonal methods","pmids":["28842499"],"is_preprint":false},{"year":2009,"finding":"Cisplatin binds to ATP7B and stimulates catalytic phosphorylation (EC50 similar to copper), but unlike copper it does not induce trafficking of ATP7B in hepatoma cells and does not compete with copper in a transport assay. Deletion of the first four copper-binding sites of ATP7B abolishes cisplatin-induced phosphorylation; mutation of the first five sites does not. These data indicate that cisplatin interacts functionally with ATP7B but is not actively transported through the copper translocation pathway.","method":"ATPase phosphorylation assay, copper transport competition assay, confocal microscopy (trafficking), site-directed deletion mutagenesis in Huh7 hepatoma cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic assay with mutagenesis and functional trafficking readout; multiple orthogonal methods in single study","pmids":["19141620"],"is_preprint":false},{"year":2004,"finding":"Both ATP7A and ATP7B sequester platinum drugs (cisplatin, carboplatin, oxaliplatin) into vesicular compartments, reducing cytoplasmic platinum available to reach DNA. Fibroblasts engineered to express ATP7B showed increased platinum in isolated vesicles for all three drugs. Copper triggered ATP7A relocalization but platinum drugs did not, indicating the sequestration mechanism is distinct from the copper-stimulated trafficking response.","method":"Engineered cell lines (Menkes fibroblasts ± ATP7B or ATP7A expression), whole-cell and vesicle platinum accumulation assays, cytotoxicity assays, immunofluorescence","journal":"Molecular pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays with engineered cell lines and vesicle fractionation; single study, two orthogonal readouts","pmids":["15213293"],"is_preprint":false},{"year":2003,"finding":"H1069Q-ATP7B is trapped in the endoplasmic reticulum rather than localizing to the trans-Golgi network in both human Wilson disease patient liver tissue (immunogold EM) and in HuH-7/HepG2 hepatoma cells. Truncated ATP7B mutants show diffuse cytoplasmic distribution distinct from TGN or ER, while most missense mutants distribute similarly to wild-type.","method":"Immunogold electron microscopy of patient liver biopsies, confocal microscopy of GFP-tagged ATP7B mutants in hepatoma cells","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct subcellular localization in patient tissue and cell lines; replicated across two independent systems (patient tissue + cell lines) for the key H1069Q mutant","pmids":["12557139"],"is_preprint":false},{"year":2001,"finding":"The toxic milk (tx) mutation in murine Wilson protein (Wnd) disrupts copper-induced relocalization of Wnd in CHO cells and abolishes Wnd-mediated copper resistance. With elevated copper, wild-type Wnd accumulates in large multivesicular structures resembling late endosomes, distinct from the post-Golgi destination of ATP7A/MNK, even when both proteins are in the same cell.","method":"Transient transfection of CHO cells, copper resistance assays, colocalization immunofluorescence, ultrastructural analysis (electron microscopy)","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional copper resistance assay plus ultrastructural localization; multiple methods in single study","pmids":["11157799"],"is_preprint":false},{"year":2009,"finding":"In kidney, ATP7B does not traffic in response to elevated copper (unlike hepatic ATP7B and ATP7A), and therefore is unlikely to mediate copper export. Renal ATP7B is 2–3 kDa smaller than hepatic ATP7B, suggesting cell-specific processing; lack of trafficking is not due to absence of kinase-mediated phosphorylation or co-expression of ATP7A. Recombinant ATP7B expressed in renal cells traffics differently from in hepatic cells.","method":"Immunofluorescence microscopy, subcellular fractionation, Western blot, RT-PCR of ATP7B mRNA variants across cell types, comparison of endogenous renal vs. hepatic ATP7B","journal":"Traffic (Copenhagen, Denmark)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization with functional readout across cell types; single lab, multiple orthogonal approaches","pmids":["19416479"],"is_preprint":false},{"year":2019,"finding":"COMMD1 binds both ATP7B and phosphatidylinositol(4,5)-bisphosphate [PtdIns(4,5)P2]; COMMD1 modulates copper-responsive ATP7B trafficking through recruitment to PtdIns(4,5)P2 membranes. Decreased COMMD1 causes loss of ATP7B from lysosomes and TGN under high copper and leads to early endosome accumulation of ATP7B; excess COMMD1 also disrupts ATP7B trafficking. A COMMD1 mutant unable to bind PtdIns(4,5)P2 had little impact on ATP7B trafficking.","method":"Quantitative colocalization analysis by confocal microscopy, siRNA knockdown and overexpression of COMMD1, PtdIns(4,5)P2-binding mutant of COMMD1 in HepG2 cells","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — quantitative localization with gain- and loss-of-function and domain mutant; single lab","pmids":["31515276"],"is_preprint":false},{"year":2023,"finding":"ATP7B and ATP7A reside on distinct TGN domains under limiting copper. In high copper, ATP7B traffics to the apical membrane via common recycling endosomes, apical sorting endosomes, and apical recycling endosomes (transcytotic route), while ATP7A traffics basolaterally. The AP-1A complex provides directionality and TGN retention for both Cu-ATPases; the AP-1B complex governs copper-independent trafficking of ATP7B to the apical domain specifically. Knockout of pan-AP-1 disrupts sorting of both ATPases.","method":"Polarized epithelial cell imaging (confocal microscopy), mass spectrometry identification of regulatory partners, AP-1A and AP-1B isoform-specific CRISPR knockouts, analysis of Wilson disease-causing ATP7B trafficking mutants","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 / Moderate — MS-based partner identification combined with isoform-specific KO and disease mutant analysis; multiple orthogonal methods in single study","pmids":["38032054"],"is_preprint":false},{"year":2009,"finding":"Wilson disease mutations that cause protein misfolding result in reduced ATP7B expression (protein but not mRNA) and ER retention. Culturing cells at 30°C increases expression and normalizes localization of mutant ATP7B. Four distinct mutations retained residual copper export capacity. Pharmacological chaperones 4-phenylbutyrate (4-PBA) and curcumin partially restored protein expression of most ATP7B mutants.","method":"Western blot, immunofluorescence microscopy, copper export assays, temperature-rescue experiments, homology modeling, pharmacological chaperone treatment in transfected cell lines","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — systematic analysis of multiple mutants with functional copper export assay, temperature rescue, and pharmacological correction; single lab, multiple orthogonal methods","pmids":["19937698"],"is_preprint":false},{"year":2012,"finding":"ATP7B variants causing Wilson disease disrupt the protein's function through diverse mechanisms: some cause complete loss of catalytic and transport activity; others lose transport activity but retain phosphointermediate formation; yet others have partial activity losses. Transport-competent variants differ in stability and subcellular localization in mammalian cells.","method":"Baculovirus/Sf9 expression system, ATPase catalytic activity assay, 64Cu transport into vesicles, GFP-tagged protein localization by confocal microscopy in mammalian cells","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — reconstituted transport assay in vesicles with radiotracer, catalytic activity measurement, and localization; multiple orthogonal methods for 28 variants","pmids":["22240481"],"is_preprint":false},{"year":2016,"finding":"ATP7B in intestinal enterocytes maintains a copper gradient along the duodenal crypt-villus axis; it buffers copper levels in the cytosol via rapid copper-dependent enlargement of ATP7B-containing vesicles and increased ATP7B levels. Loss of intestinal ATP7B (Atp7b-/- mice) causes reduced copper storage pools, accumulation of triglyceride-filled vesicles, mislocalization of apolipoprotein B, and loss of chylomicrons, linking ATP7B-mediated copper buffering to chylomicron assembly.","method":"Immunohistochemistry, X-ray fluorescence for copper distribution, electron microscopy, immunoblotting in Atp7b-/- mice; fluorescent confocal microscopy of primary 3D enteroids with copper treatment and chelation","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — loss-of-function mouse model with multiple tissue-level and organoid readouts plus direct localization experiments; multiple orthogonal methods","pmids":["28958857"],"is_preprint":false},{"year":2008,"finding":"Copper-induced translocation of ATP7B from Golgi to dispersed vesicles is independent of Rab7-regulated endolysosomal trafficking and independent of COMMD1/Murr1: RNAi depletion of COMMD1 or Rab7 (or dominant-negative Rab7) did not impair ATP7B translocation; no colocalization of translocating ATP7B with COMMD1 or Rab7 markers was observed. COMMD1 acts at a later step in the copper excretion pathway.","method":"Confocal microscopy, siRNA knockdown of COMMD1 and Rab7, dominant-negative Rab7 expression in multiple non-hepatic cell lines","journal":"The American journal of pathology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — negative epistasis result established by RNAi in multiple cell lines; single lab, two approaches (siRNA + dominant negative)","pmids":["18974300"],"is_preprint":false},{"year":2016,"finding":"Transcription factor EB (TFEB) directly binds to CLEAR (coordinated lysosomal expression and regulation) sites in the proximal promoter and first intron of ATP7B upon platinum exposure, driving ATP7B transcription in platinum-resistant ovarian cancer cells. Suppression of TFEB inhibits ATP7B expression and increases cisplatin toxicity in resistant cells.","method":"ChIP assay (TFEB binding to ATP7B CLEAR elements), luciferase reporter assays with ATP7B promoter fragments, TFEB siRNA knockdown, cisplatin sensitivity assays in IGROV-CP20 cells","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP plus reporter gene assay plus functional knockdown; single lab, two orthogonal methods confirming transcriptional regulation","pmids":["35053335"],"is_preprint":false},{"year":2019,"finding":"MTF1 (metal regulatory transcription factor 1) specifically binds to the metal-responsive element MREe in the ATP7B promoter, and this interaction significantly increases ATP7B promoter-driven reporter gene expression, identifying MTF1 as a transcriptional regulator of ATP7B.","method":"Electrophoretic mobility shift assay (EMSA), MatInspector computational analysis followed by experimental EMSA validation, luciferase reporter assay","journal":"Annals of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — EMSA (direct protein-DNA binding) plus functional reporter assay; single lab, two orthogonal methods","pmids":["31596515"],"is_preprint":false},{"year":2020,"finding":"The frequent H1069Q substitution promotes ATP7B interaction with HSP70, accelerating ER-associated degradation of the mutant protein and causing copper accumulation in hepatic cells. The HSP70 inhibitor domperidone (an FDA-approved drug) impairs HSP70–ATP7B-H1069Q interaction, recovering trafficking and function of the mutant protein.","method":"Proteomics (protein interaction landscape of H1069Q vs. wild-type ATP7B), HSP70 inhibitor experiments, copper accumulation assays, confocal microscopy of mutant ATP7B trafficking in hepatic cells","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — proteomic identification of interaction combined with functional pharmacological rescue and trafficking assays; multiple orthogonal methods","pmids":["33288711"],"is_preprint":false},{"year":2021,"finding":"ATP7B directly interacts with LC3B via a conserved LC3-interaction region (LIR3) at the C-terminal end of ATP7B; replacing the conserved hydrophobic residues W1452 and L1455 significantly reduced interaction. Autophagy induction enhances colocalization of ATP7B and LC3B on autophagosome membranes in HepG2 cells. ATP7B-deficient HepG2 cells show autophagy deficiency under elevated copper, complemented by re-expression of ATP7B.","method":"In silico LIR prediction, in vitro pulldown/binding assay (LIR3 peptide with LC3B), site-directed mutagenesis of LIR3, confocal colocalization in HepG2 cells, CRISPR ATP7B-knockout HepG2 cells with autophagy readouts","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro binding assay with mutagenesis plus cell-based colocalization and KO rescue; single lab, two orthogonal methods","pmids":["34831341"],"is_preprint":false},{"year":2016,"finding":"ATP7B traffics from TGN to the bile canaliculus via basolateral sorting, endocytosis, and microtubule-mediated transcytosis through the subapical compartment; trafficking ATP7B is not incorporated into lysosomes. Copper addition does not cause relocalization of lysosomes or appearance of lysosome markers at the bile canaliculus, arguing against the lysosomal exocytosis model for biliary copper excretion.","method":"Live-cell and fixed confocal microscopy in polarized hepatocyte (WIF-B) cells, colocalization with organelle markers, copper treatment, lysosome marker tracking","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization in polarized cells with copper stimulation and organelle markers; single lab, contradicts some other studies; moderate confidence due to conflicting literature","pmids":["27034138"],"is_preprint":false},{"year":2003,"finding":"Loss of ATP7B in adrenal glands of Atp7b-/- mice causes reduced levels of dopamine beta-hydroxylase (DBH) protein and its products norepinephrine and epinephrine, even though Atp7b mRNA is not normally expressed in adrenal tissue. This indicates that copper-requiring enzymes in tissues remote from those expressing ATP7B are affected secondarily through systemic copper dysregulation.","method":"Western blot and catecholamine measurement in Atp7b-/- vs. wild-type mouse adrenal glands; RT-PCR to confirm absence of Atp7b mRNA in adrenal; copper level measurement","journal":"Neurochemical research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function mouse model with specific biochemical phenotype; indirect/secondary effect demonstrated by absence of Atp7b mRNA; single lab","pmids":["12718440"],"is_preprint":false},{"year":2023,"finding":"During postnatal development, Atp7b is necessary for normal morphology and function of choroid plexus (ChPl); loss of Atp7b causes reorganization of ChPl cytoskeleton and cell-cell contacts, loss of Slc31a1 from the apical membrane, and decreased microvilli and cilia length and number. In ChPl lacking Atp7b, Atp7a is upregulated but remains intracellular, limiting copper transport into the brain and causing transient copper deficit with catecholamine imbalance and brain lipidome changes.","method":"Immunohistochemistry, Western blot, mass spectrometry (brain lipidome), RT-PCR, immunofluorescence microscopy in Atp7b-/- mouse choroid plexus","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function mouse model with direct morphological, biochemical, and lipidomic readouts; single lab, multiple phenotypic assays","pmids":["36626371"],"is_preprint":false},{"year":1997,"finding":"Lymphoblast cell lines from Wilson disease patients homozygous for H1069Q and four other ATP7B mutations all demonstrated significantly decreased copper-stimulated ATPase activity, establishing that these mutations directly impair the enzymatic function of ATP7B.","method":"ATPase activity assay in patient-derived lymphoblast cell lines","journal":"American journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — enzymatic activity assay in patient-derived cells; single study, single method, but direct functional measurement across multiple mutations","pmids":["9311736"],"is_preprint":false},{"year":2022,"finding":"Lack of evidence for ribosomal frameshifting in ATP7B mRNA decoding: apparent frameshifting detected with dual-luciferase polyprotein reporters was an artifact; when tested in a reporter system releasing reporters without polyprotein context, no frameshifting was detected above background. This refutes the proposed frameshifting mechanism for ATP7B expression.","method":"Dual luciferase reporter assays (two different reporter architectures), ribosome profiling data analysis, phylogenetic analysis of proposed frameshifting site","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 / Moderate — rigorous reporter assay comparison plus orthogonal ribosome profiling; single study but multiple complementary approaches clearly establishing a negative result","pmids":["36115342"],"is_preprint":false}],"current_model":"ATP7B is a P1B-type copper-transporting ATPase that uses ATP hydrolysis to translocate Cu+ across membranes via a stepwise pathway through transmembrane sulfur-containing ligands, regulated by its six N-terminal metal-binding domains (MBDs) where MBD6 delivers copper to the transmembrane entry site and MBD1-3 form an inhibitory regulatory unit; in hepatocytes it resides in the trans-Golgi network under basal conditions (delivering copper for ceruloplasmin biosynthesis), and upon copper elevation undergoes AP-1-dependent trafficking to lysosomes and/or apical vesicles via a transcytotic route, enabling lysosomal exocytosis and biliary copper excretion through interaction with dynactin p62; copper-dependent serine phosphorylation by protein kinase D stabilizes ATP7B and licenses this trafficking; protein stability is controlled by COMMD1 (proteasomal) and clusterin (lysosomal) degradation pathways, and the H1069Q disease mutant is specifically captured by HSP70 for ER-associated degradation; in intestinal enterocytes ATP7B buffers copper to support chylomicron assembly, and in the developing brain choroid plexus it maintains copper homeostasis necessary for normal brain copper delivery."},"narrative":{"mechanistic_narrative":"ATP7B is a P1B-type copper-transporting ATPase that couples ATP hydrolysis to the translocation of copper across membranes and is the central effector of cellular and systemic copper homeostasis [PMID:35245129, PMID:22240481]. Catalytic copper transport requires the conserved transmembrane CPC motif and a network of sulfur-containing transmembrane ligands that define a stepwise translocation pathway, while six N-terminal metal-binding domains (MBDs) regulate the enzyme: MBD1–3 form a regulatory unit relieved by Atox1-mediated copper delivery, and MBD6 docks at the cytoplasmic copper entry site to deliver copper to the transmembrane domain [PMID:37074913, PMID:9837819, PMID:31321400]. Under basal copper, ATP7B resides in the trans-Golgi network where it supplies copper for holoceruloplasmin biosynthesis [PMID:9430732]; upon copper elevation it undergoes a distinct, copper-dependent trafficking response — mechanistically separable from catalytic transport — to peripheral vesicles, lysosomes, and the apical/canalicular pole, enabling sequestration and excretion of excess copper into bile, with directionality conferred by AP-1 sorting complexes and lysosomal translocation aided by the dynactin subunit p62 [PMID:24909901, PMID:16472602, PMID:10942420, PMID:38032054]. This trafficking is licensed by copper-dependent serine phosphorylation by protein kinase D, which also stabilizes ATP7B against proteasomal degradation [PMID:21189263], and ATP7B abundance is further controlled by COMMD1 (proteasomal) and clusterin (lysosomal) degradation routes that act on misfolded or oxidatively stressed protein [PMID:17919502, PMID:22130675]. Beyond the liver, ATP7B buffers cytosolic copper in intestinal enterocytes to support chylomicron assembly and apolipoprotein B localization, and maintains choroid plexus copper homeostasis required for normal brain copper delivery during development [PMID:28958857, PMID:36626371]. ATP7B is the gene mutated in Wilson disease, and characterized mutations impair the protein through diverse mechanisms including loss of catalytic/transport activity, defective copper-induced trafficking, and misfolding with ER retention and accelerated degradation — the frequent H1069Q variant being trapped in the ER and captured by HSP70 for ER-associated degradation [PMID:12557139, PMID:22240481, PMID:33288711].","teleology":[{"year":1997,"claim":"Establishing that Wilson disease mutations directly impair ATP7B enzymatic function answered whether disease arises from loss of the protein's catalytic activity.","evidence":"Copper-stimulated ATPase activity assays in patient-derived lymphoblast lines carrying H1069Q and four other mutations","pmids":["9311736"],"confidence":"Medium","gaps":["Did not resolve which step of the catalytic cycle is impaired","Patient cells may carry confounding genetic background","No distinction between catalytic vs. trafficking defects"]},{"year":1998,"claim":"In vivo rescue and yeast complementation established that ATP7B functions in copper transport coupled to ceruloplasmin biosynthesis at the Golgi and that the transmembrane CPC motif is essential for transport.","evidence":"Adenoviral WND cDNA delivery into LEC rats restoring Golgi ATP7B and holoceruloplasmin; yeast ccc2 complementation with CPC→SPS mutagenesis","pmids":["9430732","9837819"],"confidence":"High","gaps":["Did not define the transmembrane copper coordination geometry","Mechanism of copper handoff to ceruloplasmin not resolved"]},{"year":2000,"claim":"Separating trafficking-competent from transport-competent mutants established that copper-induced redistribution is a distinct functional requirement from catalytic copper transport.","evidence":"Yeast complementation combined with copper-stimulated redistribution imaging of Wilson disease variants in CHO cells","pmids":["10942420"],"confidence":"High","gaps":["Trafficking signals/machinery not identified","Did not address tissue-specific trafficking differences"]},{"year":2001,"claim":"The toxic milk mutant model showed copper-induced relocalization is required for copper resistance and that ATP7B targets a distinct late-endosomal/multivesicular destination separate from ATP7A.","evidence":"Transfection of CHO cells with mutant Wnd, copper resistance assays, and ultrastructural colocalization","pmids":["11157799"],"confidence":"High","gaps":["Molecular basis of distinct destination unresolved","Late endosome identity not definitively marked"]},{"year":2003,"claim":"Localizing H1069Q to the ER and documenting secondary catecholamine enzyme deficits clarified that the most common mutation causes ER retention and that systemic copper dysregulation affects copper enzymes in non-expressing tissues.","evidence":"Immunogold EM of patient liver plus GFP-mutant imaging; Western blot/catecholamine measurement in Atp7b-/- adrenal glands","pmids":["12557139","12718440"],"confidence":"High","gaps":["ER quality-control machinery acting on H1069Q not yet identified","Adrenal effect is secondary/indirect, not a direct ATP7B function"]},{"year":2006,"claim":"Demonstrating vesicular copper sequestration and exocytosis refined the excretion model away from direct canalicular membrane translocation.","evidence":"Immunofluorescence and copper accumulation assays in HepG2 and CHO cells with an endocytic-signal mutant","pmids":["16472602"],"confidence":"High","gaps":["Identity of the exocytic vesicle compartment not fully defined","Endocytic retrieval machinery not identified"]},{"year":2007,"claim":"Identifying COMMD1 binding to the N-terminus established a copper-independent control of ATP7B stability distinct from its trafficking.","evidence":"GST pull-down, Co-IP, pulse-chase, and mutagenesis of N-terminal Wilson disease variants","pmids":["17919502"],"confidence":"High","gaps":["Degradation pathway used by COMMD1 not specified in this study","How N-terminal mutations enhance COMMD1 binding structurally unclear"]},{"year":2008,"claim":"Epistasis testing placed copper-induced ATP7B translocation upstream of and independent from COMMD1- and Rab7-regulated endolysosomal trafficking.","evidence":"siRNA and dominant-negative Rab7 with confocal colocalization in multiple non-hepatic cell lines","pmids":["18974300"],"confidence":"Medium","gaps":["Negative result; non-hepatic cells may differ from hepatocytes","Exact step where COMMD1 acts not pinpointed here"]},{"year":2009,"claim":"Catalytic-cycle and pharmacological-chaperone studies dissected the spectrum of mutant defects and showed cisplatin engages ATP7B catalytically but is not transported through the copper pathway.","evidence":"Phosphorylation/transport competition assays with deletion mutants in Huh7 cells; copper export, temperature-rescue and 4-PBA/curcumin treatment of misfolding mutants; cell-type comparison of renal vs. hepatic trafficking","pmids":["19141620","19937698","19416479"],"confidence":"High","gaps":["Why cisplatin uncouples phosphorylation from trafficking unresolved","Tissue-specific processing basis for renal non-trafficking not identified"]},{"year":2010,"claim":"Identifying PKD phosphorylation explained how copper licenses both ATP7B stability and Golgi-to-vesicle trafficking.","evidence":"Microsomal phosphorylation assays with PKD inhibitor, serine-to-alanine mutagenesis, and trafficking imaging in COS-1/HepG2 cells","pmids":["21189263"],"confidence":"High","gaps":["How copper binding activates PKD toward ATP7B unclear","Phosphatase counteracting this modification not identified"]},{"year":2011,"claim":"Resolving two parallel degradation routes (clusterin/lysosomal, COMMD1/proteasomal) defined non-redundant quality-control pathways governing ATP7B abundance.","evidence":"Reciprocal Co-IP, knockdown/overexpression, and lysosomal/proteasomal inhibitor experiments on endogenous ATP7B","pmids":["22130675"],"confidence":"High","gaps":["Signals selecting one route vs. the other not defined","E3 ligase mediating COMMD1-linked proteasomal degradation unidentified"]},{"year":2012,"claim":"Systematic reconstitution of 28 disease variants categorized mutations into catalytic, transport, phosphointermediate, and stability/localization defect classes.","evidence":"Baculovirus/Sf9 ATPase and 64Cu vesicular transport assays with GFP-localization in mammalian cells","pmids":["22240481"],"confidence":"High","gaps":["In-cell trafficking behavior of all variants not exhaustively mapped","Genotype-phenotype correlation to clinical severity not established here"]},{"year":2014,"claim":"Linking ATP7B to lysosomal copper import and dynactin-p62-driven lysosomal exocytosis provided a mechanism for biliary copper excretion.","evidence":"Live-cell imaging, ATP7B–p62/dynactin Co-IP, siRNA, and copper excretion assays in HepG2 and primary hepatocytes","pmids":["24909901"],"confidence":"High","gaps":["Reconciling lysosomal exocytosis with transcytotic models unresolved","How copper is released across the canalicular membrane not defined"]},{"year":2016,"claim":"Demonstrating an intestinal copper-buffering role connected ATP7B to chylomicron assembly, and a polarized-hepatocyte study challenged the lysosomal exocytosis model in favor of microtubule-mediated transcytosis.","evidence":"X-ray fluorescence, EM, and enteroid imaging in Atp7b-/- mice; live-cell confocal organelle-marker tracking in polarized WIF-B cells","pmids":["28958857","27034138"],"confidence":"Medium","gaps":["Conflicting excretion routes (lysosomal vs. transcytotic) not reconciled","Mechanistic link between copper buffering and apoB localization incomplete"]},{"year":2017,"claim":"Showing ATP7B forms stable dimers retained during trafficking provided the first architectural view of a human Cu-ATPase.","evidence":"Co-IP of differentially tagged variants and negative-stain EM of purified dimeric construct","pmids":["28842499"],"confidence":"Medium","gaps":["Functional role of dimerization in transport/trafficking unknown","Low-resolution model; high-resolution dimer interface not defined"]},{"year":2019,"claim":"Defining the MBD copper-relay hierarchy and COMMD1–PtdIns(4,5)P2 coupling clarified intramolecular regulation and membrane-recruitment control of trafficking, and identified MTF1 as a metal-responsive transcriptional regulator.","evidence":"Yeast transport assays with cysteine-to-serine MBD mutants; quantitative colocalization with COMMD1 PtdIns(4,5)P2-binding mutant in HepG2 cells; EMSA and reporter assays for MTF1","pmids":["31321400","31515276","31596515"],"confidence":"Medium","gaps":["Structural basis of MBD1–3 inhibition not directly visualized here","How COMMD1 lipid binding directs ATP7B at specific membranes incomplete"]},{"year":2020,"claim":"Identifying HSP70 capture of H1069Q and its pharmacological reversal defined a druggable basis for the most common Wilson disease defect.","evidence":"Proteomic interaction profiling, HSP70 inhibitor (domperidone) treatment, and trafficking/copper accumulation assays in hepatic cells","pmids":["33288711"],"confidence":"High","gaps":["Whether HSP70 targeting generalizes to other misfolding mutants unclear","In vivo efficacy of HSP70 inhibition not established here"]},{"year":2021,"claim":"Identifying an LC3-interaction region linked ATP7B directly to autophagy regulation under copper stress.","evidence":"In vitro LIR3 peptide binding with mutagenesis and colocalization/KO-rescue autophagy readouts in HepG2 cells","pmids":["34831341"],"confidence":"Medium","gaps":["Single-lab finding; in vitro binding not confirmed for full-length protein in vivo","Physiological consequence of ATP7B–LC3B interaction incompletely defined"]},{"year":2022,"claim":"Cryo-EM of the E2-Pi state and a rigorous negative result on frameshifting clarified, respectively, the transmembrane copper pathway/regulation and that ATP7B is decoded without ribosomal frameshifting.","evidence":"Cryo-EM of frog ATP7B; dual-luciferase reporter comparison plus ribosome profiling analysis for frameshifting","pmids":["35245129","36115342"],"confidence":"High","gaps":["Copper-bound and trafficking-competent conformations not captured in E2-Pi state","Functional asymmetry of dimer not addressed by monomeric structure"]},{"year":2023,"claim":"Human E1-state cryo-EM, AP-1-dependent polarized sorting, and the choroid plexus phenotype together resolved MBD6 docking at the copper entry site, the apical transcytotic route directed by AP-1, and a developmental brain copper-delivery role.","evidence":"Cryo-EM of human ATP7B in three states; polarized-cell imaging with AP-1A/AP-1B CRISPR KO and MS partner ID; Atp7b-/- choroid plexus IHC, lipidomics, and immunofluorescence","pmids":["37074913","38032054","36626371"],"confidence":"High","gaps":["Full copper-translocation cycle intermediates still incompletely resolved","How AP-1B isoform selectivity is achieved mechanistically unclear","Reconciliation of apical transcytotic vs. lysosomal excretion routes still open"]},{"year":null,"claim":"How the conflicting models of biliary copper excretion (lysosomal exocytosis vs. microtubule-mediated transcytosis) are reconciled, and how copper is ultimately released across the canalicular membrane, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model integrating lysosomal and transcytotic excretion routes","Mechanism of final copper release into bile undefined","Tissue-specific trafficking regulation across liver, intestine, kidney, and brain not mechanistically unified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140657","term_label":"ATP-dependent activity","supporting_discovery_ids":[0,1,5,20]},{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[3,4,5,10,20]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[12,20,30]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[4,14,9]},{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[2,8]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[3,15,21]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[14,19,25]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[18]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[17,18]}],"pathway":[{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[4,5,20,3]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[2,18,3]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[4,21,28]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[14,25,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7,8,25]}],"complexes":[],"partners":["COMMD1","ATOX1","CLU","DCTN4","HSPA1A","MAP1LC3B","PRKD1","TFEB"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P35670","full_name":"Copper-transporting ATPase 2","aliases":["Copper pump 2","Wilson disease-associated protein"],"length_aa":1465,"mass_kda":157.3,"function":"Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P35670/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ATP7B","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/ATP7B","total_profiled":1310},"omim":[{"mim_id":"620009","title":"KERATODERMA-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KDIDAR","url":"https://www.omim.org/entry/620009"},{"mim_id":"614758","title":"DYNACTIN 4; DCTN4","url":"https://www.omim.org/entry/614758"},{"mim_id":"614482","title":"HUPPKE-BRENDEL SYNDROME; HPBDS","url":"https://www.omim.org/entry/614482"},{"mim_id":"610232","title":"ATPase 13A3; ATP13A3","url":"https://www.omim.org/entry/610232"},{"mim_id":"608552","title":"VPS33B LATE ENDOSOME AND LYSOSOME ASSOCIATED; VPS33B","url":"https://www.omim.org/entry/608552"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":10.0}],"url":"https://www.proteinatlas.org/search/ATP7B"},"hgnc":{"alias_symbol":[],"prev_symbol":["WND"]},"alphafold":{"accession":"P35670","domains":[{"cath_id":"3.30.70.100","chopping":"59-126","consensus_level":"high","plddt":84.6609,"start":59,"end":126},{"cath_id":"3.30.70.100","chopping":"144-215","consensus_level":"high","plddt":86.3214,"start":144,"end":215},{"cath_id":"3.30.70.100","chopping":"258-326","consensus_level":"high","plddt":83.38,"start":258,"end":326},{"cath_id":"3.30.70.100","chopping":"360-429","consensus_level":"high","plddt":85.424,"start":360,"end":429},{"cath_id":"3.30.70.100","chopping":"499-557","consensus_level":"medium","plddt":77.3698,"start":499,"end":557},{"cath_id":"3.30.70.100","chopping":"567-635","consensus_level":"medium","plddt":83.253,"start":567,"end":635},{"cath_id":"2.70.150.10","chopping":"801-855_868-896","consensus_level":"medium","plddt":83.8381,"start":801,"end":896},{"cath_id":"3.40.1110.10","chopping":"1034-1114_1143-1198","consensus_level":"high","plddt":84.3788,"start":1034,"end":1198}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P35670","model_url":"https://alphafold.ebi.ac.uk/files/AF-P35670-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P35670-F1-predicted_aligned_error_v6.png","plddt_mean":71.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ATP7B","jax_strain_url":"https://www.jax.org/strain/search?query=ATP7B"},"sequence":{"accession":"P35670","fasta_url":"https://rest.uniprot.org/uniprotkb/P35670.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P35670/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P35670"}},"corpus_meta":[{"pmid":"17531189","id":"PMC_17531189","title":"Trafficking of the copper-ATPases, ATP7A and ATP7B: role in copper homeostasis.","date":"2007","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/17531189","citation_count":357,"is_preprint":false},{"pmid":"9311736","id":"PMC_9311736","title":"Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9311736","citation_count":258,"is_preprint":false},{"pmid":"24909901","id":"PMC_24909901","title":"Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/24909901","citation_count":235,"is_preprint":false},{"pmid":"16791614","id":"PMC_16791614","title":"Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16791614","citation_count":188,"is_preprint":false},{"pmid":"9430732","id":"PMC_9430732","title":"Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9430732","citation_count":135,"is_preprint":false},{"pmid":"17919502","id":"PMC_17919502","title":"Distinct Wilson's disease mutations in ATP7B are associated with enhanced binding to COMMD1 and reduced stability of ATP7B.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17919502","citation_count":127,"is_preprint":false},{"pmid":"9837819","id":"PMC_9837819","title":"Functional characterization of missense mutations in ATP7B: Wilson disease mutation or normal variant?","date":"1998","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9837819","citation_count":126,"is_preprint":false},{"pmid":"10942420","id":"PMC_10942420","title":"Copper-dependent trafficking of Wilson disease mutant ATP7B proteins.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10942420","citation_count":124,"is_preprint":false},{"pmid":"22240481","id":"PMC_22240481","title":"Diverse functional properties of Wilson disease ATP7B variants.","date":"2012","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22240481","citation_count":123,"is_preprint":false},{"pmid":"15213293","id":"PMC_15213293","title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B.","date":"2004","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15213293","citation_count":119,"is_preprint":false},{"pmid":"12216079","id":"PMC_12216079","title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP.","date":"2002","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12216079","citation_count":117,"is_preprint":false},{"pmid":"19470734","id":"PMC_19470734","title":"Therapeutic Targeting of ATP7B in Ovarian Carcinoma.","date":"2009","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/19470734","citation_count":117,"is_preprint":false},{"pmid":"15519648","id":"PMC_15519648","title":"The H1069Q mutation in ATP7B is associated with late and neurologic presentation in Wilson disease: results of a meta-analysis.","date":"2004","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/15519648","citation_count":112,"is_preprint":false},{"pmid":"15967699","id":"PMC_15967699","title":"Mutation analysis of the ATP7B gene and genotype/phenotype correlation in 227 patients with Wilson disease.","date":"2005","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15967699","citation_count":112,"is_preprint":false},{"pmid":"16472602","id":"PMC_16472602","title":"ATP7B mediates vesicular sequestration of copper: insight into biliary copper excretion.","date":"2006","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/16472602","citation_count":109,"is_preprint":false},{"pmid":"19937698","id":"PMC_19937698","title":"Reduced expression of ATP7B affected by Wilson disease-causing mutations is rescued by pharmacological folding chaperones 4-phenylbutyrate and curcumin.","date":"2009","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19937698","citation_count":107,"is_preprint":false},{"pmid":"12557139","id":"PMC_12557139","title":"Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.","date":"2003","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/12557139","citation_count":100,"is_preprint":false},{"pmid":"18000748","id":"PMC_18000748","title":"Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins.","date":"2007","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/18000748","citation_count":92,"is_preprint":false},{"pmid":"28958857","id":"PMC_28958857","title":"The Function of ATPase Copper Transporter ATP7B in Intestine.","date":"2017","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/28958857","citation_count":91,"is_preprint":false},{"pmid":"15024742","id":"PMC_15024742","title":"Wilson disease: novel mutations in the ATP7B gene and clinical correlation in Brazilian patients.","date":"2004","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15024742","citation_count":86,"is_preprint":false},{"pmid":"26679751","id":"PMC_26679751","title":"Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B(-/-) (Wilson disease) mice.","date":"2016","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/26679751","citation_count":84,"is_preprint":false},{"pmid":"27022412","id":"PMC_27022412","title":"Spectrum and Classification of ATP7B Variants in a Large Cohort of Chinese Patients with Wilson's Disease Guides Genetic Diagnosis.","date":"2016","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/27022412","citation_count":83,"is_preprint":false},{"pmid":"9785470","id":"PMC_9785470","title":"ATP7B (WND) protein.","date":"1998","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9785470","citation_count":79,"is_preprint":false},{"pmid":"11157799","id":"PMC_11157799","title":"Effect of the toxic milk mutation (tx) on the function and intracellular localization of Wnd, the murine homologue of the Wilson copper ATPase.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11157799","citation_count":74,"is_preprint":false},{"pmid":"22130675","id":"PMC_22130675","title":"Clusterin and COMMD1 independently regulate degradation of the mammalian copper ATPases ATP7A and ATP7B.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22130675","citation_count":74,"is_preprint":false},{"pmid":"35245129","id":"PMC_35245129","title":"Structure of the Wilson disease copper transporter ATP7B.","date":"2022","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/35245129","citation_count":73,"is_preprint":false},{"pmid":"17268820","id":"PMC_17268820","title":"Hepatic copper-transporting ATPase ATP7B: function and inactivation at the molecular and cellular level.","date":"2007","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17268820","citation_count":69,"is_preprint":false},{"pmid":"19021531","id":"PMC_19021531","title":"Atp7b-/- mice as a model for studies of Wilson's disease.","date":"2008","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/19021531","citation_count":68,"is_preprint":false},{"pmid":"34209820","id":"PMC_34209820","title":"Copper Imbalance in Alzheimer's Disease: Meta-Analysis of Serum, Plasma, and Brain Specimens, and Replication Study Evaluating ATP7B Gene Variants.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/34209820","citation_count":66,"is_preprint":false},{"pmid":"14986826","id":"PMC_14986826","title":"Mutation spectrum and polymorphisms in ATP7B identified on direct sequencing of all exons in Chinese Han and Hui ethnic patients with Wilson's disease.","date":"2003","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14986826","citation_count":66,"is_preprint":false},{"pmid":"33640437","id":"PMC_33640437","title":"Direct Measurement of ATP7B Peptides Is Highly Effective in the Diagnosis of Wilson Disease.","date":"2021","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/33640437","citation_count":63,"is_preprint":false},{"pmid":"26207595","id":"PMC_26207595","title":"Geographic distribution of ATP7B mutations in Wilson disease.","date":"2015","source":"Annals of human biology","url":"https://pubmed.ncbi.nlm.nih.gov/26207595","citation_count":61,"is_preprint":false},{"pmid":"16211609","id":"PMC_16211609","title":"p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease.","date":"2006","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/16211609","citation_count":58,"is_preprint":false},{"pmid":"32248359","id":"PMC_32248359","title":"ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease.","date":"2020","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32248359","citation_count":52,"is_preprint":false},{"pmid":"19141620","id":"PMC_19141620","title":"Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19141620","citation_count":52,"is_preprint":false},{"pmid":"12539962","id":"PMC_12539962","title":"Human copper-transporting ATPase ATP7B (the Wilson's disease protein): biochemical properties and regulation.","date":"2002","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/12539962","citation_count":51,"is_preprint":false},{"pmid":"19416479","id":"PMC_19416479","title":"Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage.","date":"2009","source":"Traffic (Copenhagen, Denmark)","url":"https://pubmed.ncbi.nlm.nih.gov/19416479","citation_count":51,"is_preprint":false},{"pmid":"35923305","id":"PMC_35923305","title":"Cuproptosis-Related Gene - SLC31A1, FDX1 and ATP7B - Polymorphisms are Associated with Risk of Lung Cancer.","date":"2022","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35923305","citation_count":50,"is_preprint":false},{"pmid":"31924743","id":"PMC_31924743","title":"Metabolic dysregulation in the Atp7b-/- Wilson's disease mouse model.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31924743","citation_count":50,"is_preprint":false},{"pmid":"38186308","id":"PMC_38186308","title":"Combination of the cuproptosis inducer disulfiram and anti‑PD‑L1 abolishes NSCLC resistance by ATP7B to regulate the HIF‑1 signaling pathway.","date":"2024","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/38186308","citation_count":48,"is_preprint":false},{"pmid":"17587212","id":"PMC_17587212","title":"Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease.","date":"2007","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/17587212","citation_count":48,"is_preprint":false},{"pmid":"22950421","id":"PMC_22950421","title":"Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.","date":"2013","source":"Rejuvenation research","url":"https://pubmed.ncbi.nlm.nih.gov/22950421","citation_count":46,"is_preprint":false},{"pmid":"11802810","id":"PMC_11802810","title":"Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human breast carcinoma.","date":"2002","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/11802810","citation_count":46,"is_preprint":false},{"pmid":"27499330","id":"PMC_27499330","title":"Non-ceruloplasmin bound copper and ATP7B gene variants in Alzheimer's disease.","date":"2016","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/27499330","citation_count":44,"is_preprint":false},{"pmid":"37074913","id":"PMC_37074913","title":"Structures of the human Wilson disease copper transporter ATP7B.","date":"2023","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/37074913","citation_count":44,"is_preprint":false},{"pmid":"28271598","id":"PMC_28271598","title":"Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A.","date":"2017","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/28271598","citation_count":42,"is_preprint":false},{"pmid":"27982432","id":"PMC_27982432","title":"Spectrum of ATP7B mutations and genotype-phenotype correlation in large-scale Chinese patients with Wilson Disease.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27982432","citation_count":41,"is_preprint":false},{"pmid":"30230192","id":"PMC_30230192","title":"Whole-exome sequencing identifies novel pathogenic variants across the ATP7B gene and some modifiers of Wilson's disease phenotype.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/30230192","citation_count":41,"is_preprint":false},{"pmid":"35340061","id":"PMC_35340061","title":"ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.","date":"2022","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35340061","citation_count":36,"is_preprint":false},{"pmid":"23904612","id":"PMC_23904612","title":"Independent pathways downstream of the Wnd/DLK MAPKKK regulate synaptic structure, axonal transport, and injury signaling.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23904612","citation_count":35,"is_preprint":false},{"pmid":"21189263","id":"PMC_21189263","title":"Involvement of protein kinase D in expression and trafficking of ATP7B (copper ATPase).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21189263","citation_count":35,"is_preprint":false},{"pmid":"38397079","id":"PMC_38397079","title":"Epidemiology of Wilson's Disease and Pathogenic Variants of the ATP7B Gene Leading to Diversified Protein Disfunctions.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38397079","citation_count":34,"is_preprint":false},{"pmid":"18974300","id":"PMC_18974300","title":"Copper-induced translocation of the Wilson disease protein ATP7B independent of Murr1/COMMD1 and Rab7.","date":"2008","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/18974300","citation_count":33,"is_preprint":false},{"pmid":"15681833","id":"PMC_15681833","title":"The Wilson disease protein ATP7B resides in the late endosomes with Rab7 and the Niemann-Pick C1 protein.","date":"2005","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15681833","citation_count":33,"is_preprint":false},{"pmid":"28842499","id":"PMC_28842499","title":"Human copper transporter ATP7B (Wilson disease protein) forms stable dimers in vitro and in cells.","date":"2017","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/28842499","citation_count":32,"is_preprint":false},{"pmid":"31790150","id":"PMC_31790150","title":"Copper-dependent ATP7B up-regulation drives the resistance of TMEM16A-overexpressing head-and-neck cancer models to platinum toxicity.","date":"2019","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/31790150","citation_count":32,"is_preprint":false},{"pmid":"20836889","id":"PMC_20836889","title":"Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.","date":"2010","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/20836889","citation_count":31,"is_preprint":false},{"pmid":"18373411","id":"PMC_18373411","title":"New mutations in the Wilson disease gene, ATP7B: implications for molecular testing.","date":"2008","source":"Genetic testing","url":"https://pubmed.ncbi.nlm.nih.gov/18373411","citation_count":30,"is_preprint":false},{"pmid":"28925357","id":"PMC_28925357","title":"Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28925357","citation_count":29,"is_preprint":false},{"pmid":"24697742","id":"PMC_24697742","title":"Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.","date":"2014","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/24697742","citation_count":29,"is_preprint":false},{"pmid":"22158007","id":"PMC_22158007","title":"Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.","date":"2011","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/22158007","citation_count":28,"is_preprint":false},{"pmid":"27398169","id":"PMC_27398169","title":"Mutational analysis of ATP7B in Chinese Wilson disease patients.","date":"2016","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/27398169","citation_count":27,"is_preprint":false},{"pmid":"20931554","id":"PMC_20931554","title":"Mutation analysis and characterization of alternative splice variants of the Wilson disease gene ATP7B.","date":"2010","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/20931554","citation_count":27,"is_preprint":false},{"pmid":"36092366","id":"PMC_36092366","title":"Full-length ATP7B reconstituted through protein trans-splicing corrects Wilson disease in mice.","date":"2022","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/36092366","citation_count":26,"is_preprint":false},{"pmid":"29637721","id":"PMC_29637721","title":"Presumed missense and synonymous mutations in ATP7B gene cause exon skipping in Wilson disease.","date":"2018","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/29637721","citation_count":26,"is_preprint":false},{"pmid":"12372948","id":"PMC_12372948","title":"Expression in mouse kidney of membrane copper transporters Atp7a and Atp7b.","date":"2002","source":"Nephron","url":"https://pubmed.ncbi.nlm.nih.gov/12372948","citation_count":26,"is_preprint":false},{"pmid":"25961917","id":"PMC_25961917","title":"Rho1-Wnd signaling regulates loss-of-cell polarity-induced cell invasion in Drosophila.","date":"2015","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/25961917","citation_count":25,"is_preprint":false},{"pmid":"35053335","id":"PMC_35053335","title":"TFEB Regulates ATP7B Expression to Promote Platinum Chemoresistance in Human Ovarian Cancer Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35053335","citation_count":25,"is_preprint":false},{"pmid":"9587140","id":"PMC_9587140","title":"Physiologic function of the Wilson disease gene product, ATP7B.","date":"1998","source":"The American journal of clinical nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/9587140","citation_count":25,"is_preprint":false},{"pmid":"12718440","id":"PMC_12718440","title":"A mutation in the ATP7B copper transporter causes reduced dopamine beta-hydroxylase and norepinephrine in mouse adrenal.","date":"2003","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/12718440","citation_count":25,"is_preprint":false},{"pmid":"31515276","id":"PMC_31515276","title":"COMMD1 and PtdIns(4,5)P2 interaction maintain ATP7B copper transporter trafficking fidelity in HepG2 cells.","date":"2019","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/31515276","citation_count":24,"is_preprint":false},{"pmid":"32446740","id":"PMC_32446740","title":"Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32446740","citation_count":24,"is_preprint":false},{"pmid":"34470610","id":"PMC_34470610","title":"Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease.","date":"2021","source":"BMC gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/34470610","citation_count":23,"is_preprint":false},{"pmid":"34831341","id":"PMC_34831341","title":"Direct Interaction of ATP7B and LC3B Proteins Suggests a Cooperative Role of Copper Transportation and Autophagy.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34831341","citation_count":23,"is_preprint":false},{"pmid":"38032054","id":"PMC_38032054","title":"Regulation of the apico-basolateral trafficking polarity of the homologous copper-ATPases ATP7A and ATP7B.","date":"2023","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/38032054","citation_count":22,"is_preprint":false},{"pmid":"16377579","id":"PMC_16377579","title":"Expression of ATP7B in normal human liver.","date":"2005","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/16377579","citation_count":22,"is_preprint":false},{"pmid":"31321400","id":"PMC_31321400","title":"Copper relay path through the N-terminus of Wilson disease protein, ATP7B.","date":"2019","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/31321400","citation_count":20,"is_preprint":false},{"pmid":"36626371","id":"PMC_36626371","title":"Atp7b-dependent choroid plexus dysfunction causes transient copper deficit and metabolic changes in the developing mouse brain.","date":"2023","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36626371","citation_count":19,"is_preprint":false},{"pmid":"27122662","id":"PMC_27122662","title":"Functional analysis and drug response to zinc and D-penicillamine in stable ATP7B mutant hepatic cell lines.","date":"2016","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/27122662","citation_count":19,"is_preprint":false},{"pmid":"39581695","id":"PMC_39581695","title":"CircSpna2 attenuates cuproptosis by mediating ubiquitin ligase Keap1 to regulate the Nrf2-Atp7b signalling axis in depression after traumatic brain injury in a mouse model.","date":"2024","source":"Clinical and translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39581695","citation_count":18,"is_preprint":false},{"pmid":"31596515","id":"PMC_31596515","title":"MTF1 binds to metal-responsive element e within the ATP7B promoter and is a strong candidate in regulating the ATP7B expression.","date":"2019","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31596515","citation_count":18,"is_preprint":false},{"pmid":"15154620","id":"PMC_15154620","title":"Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) in human hepatocellular carcinoma.","date":"2004","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/15154620","citation_count":18,"is_preprint":false},{"pmid":"12579329","id":"PMC_12579329","title":"Wilson disease protein ATP7B is localized in the late endosomes in a polarized human hepatocyte cell line.","date":"2003","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12579329","citation_count":18,"is_preprint":false},{"pmid":"36343861","id":"PMC_36343861","title":"Pathogenicity of Intronic and Synonymous Variants of ATP7B in Wilson Disease.","date":"2022","source":"The Journal of molecular diagnostics : JMD","url":"https://pubmed.ncbi.nlm.nih.gov/36343861","citation_count":17,"is_preprint":false},{"pmid":"32997714","id":"PMC_32997714","title":"CRISPR/Cas9-mediated correction of mutated copper transporter ATP7B.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32997714","citation_count":17,"is_preprint":false},{"pmid":"37717021","id":"PMC_37717021","title":"ATP7B R778L mutant hepatocytes resist copper toxicity by activating autophagy and inhibiting necroptosis.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37717021","citation_count":17,"is_preprint":false},{"pmid":"32155648","id":"PMC_32155648","title":"ATP7B knockout disturbs copper and lipid metabolism in Caco-2 cells.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32155648","citation_count":17,"is_preprint":false},{"pmid":"28820536","id":"PMC_28820536","title":"Atp7a and Atp7b regulate copper homeostasis in developing male germ cells in mice.","date":"2017","source":"Metallomics : integrated biometal science","url":"https://pubmed.ncbi.nlm.nih.gov/28820536","citation_count":17,"is_preprint":false},{"pmid":"31254371","id":"PMC_31254371","title":"Association of the canine ATP7A and ATP7B with hepatic copper accumulation in Dobermann dogs.","date":"2019","source":"Journal of veterinary internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31254371","citation_count":17,"is_preprint":false},{"pmid":"27034138","id":"PMC_27034138","title":"Basolateral sorting and transcytosis define the Cu+-regulated translocation of ATP7B to the bile canaliculus.","date":"2016","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/27034138","citation_count":17,"is_preprint":false},{"pmid":"21034864","id":"PMC_21034864","title":"Six novel ATP7B mutations in Thai patients with Wilson disease.","date":"2010","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21034864","citation_count":17,"is_preprint":false},{"pmid":"20362556","id":"PMC_20362556","title":"Overexpressed ATP7B protects mesenchymal stem cells from toxic copper.","date":"2010","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/20362556","citation_count":17,"is_preprint":false},{"pmid":"23333878","id":"PMC_23333878","title":"Mutation analysis of ATP7B gene in Turkish Wilson disease patients: identification of five novel mutations.","date":"2013","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23333878","citation_count":16,"is_preprint":false},{"pmid":"29732486","id":"PMC_29732486","title":"Metallothionein is elevated in liver and duodenum of Atp7b(-/-) mice.","date":"2018","source":"Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29732486","citation_count":16,"is_preprint":false},{"pmid":"36115342","id":"PMC_36115342","title":"Lack of evidence for ribosomal frameshifting in ATP7B mRNA decoding.","date":"2022","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/36115342","citation_count":16,"is_preprint":false},{"pmid":"24892424","id":"PMC_24892424","title":"The effect of zinc and D-penicillamine in a stable human hepatoma ATP7B knockout cell line.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24892424","citation_count":16,"is_preprint":false},{"pmid":"22308153","id":"PMC_22308153","title":"Prevalence of ATP7B Gene Mutations in Iranian Patients With Wilson Disease.","date":"2011","source":"Hepatitis monthly","url":"https://pubmed.ncbi.nlm.nih.gov/22308153","citation_count":16,"is_preprint":false},{"pmid":"33288711","id":"PMC_33288711","title":"Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B.","date":"2020","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33288711","citation_count":16,"is_preprint":false},{"pmid":"22966294","id":"PMC_22966294","title":"ATP7B expression is associated with in vitro sensitivity to cisplatin in non-small cell lung cancer.","date":"2010","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/22966294","citation_count":16,"is_preprint":false},{"pmid":"31059521","id":"PMC_31059521","title":"Genetic analysis of ATP7B in 102 south Indian families with Wilson disease.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31059521","citation_count":15,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48932,"output_tokens":8696,"usd":0.138618,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18907,"output_tokens":6408,"usd":0.127367,"stage2_stop_reason":"end_turn"},"total_usd":0.265985,"stage1_batch_id":"msgbatch_0179Z2pxRYBsXi2xADneafRw","stage2_batch_id":"msgbatch_01LaY9ZaVdgjWArcZo9eqQE5","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structure of frog ATP7B in a copper-free (E2-Pi) state revealed: a ring of negatively charged residues lines the cytoplasmic copper entrance gated by a conserved basic residue; a network of copper-coordinating ligands in the transmembrane domain delineates a stepwise copper transport pathway; the N-terminal metal-binding domains interact with both the A and P cytoplasmic domains, poised to exert copper-dependent regulation of ATP hydrolysis coupled to transmembrane copper transport.\",\n      \"method\": \"Cryo-electron microscopy structure determination\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with functional domain mapping; single study but Tier 1 method with detailed structural-functional analysis\",\n      \"pmids\": [\"35245129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structures of human ATP7B in the E1 state (apo, putative copper-bound, and putative cisplatin-bound forms) showed that the sixth N-terminal metal-binding domain (MBD6) binds at the cytoplasmic copper entry site of the transmembrane domain (TMD), facilitating copper delivery from MBD6 to the TMD; sulfur-containing residues in the TMD mark the copper transport pathway; comparison with E2-Pi frog ATP7B structure supports an ATP-driven copper transport model.\",\n      \"method\": \"Cryo-electron microscopy structure determination (multiple states)\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structures in three distinct states, human protein, single study with multiple orthogonal structural comparisons\",\n      \"pmids\": [\"37074913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"In response to elevated copper, ATP7B moves from the Golgi to lysosomes, imports copper into their lumen, and then enables lysosomal exocytosis through interaction with the p62 subunit of dynactin, allowing lysosome translocation toward the canalicular pole of hepatocytes for copper excretion into bile.\",\n      \"method\": \"Live-cell fluorescence microscopy, Co-IP (ATP7B–p62/dynactin), siRNA knockdown, copper accumulation/excretion assays in HepG2 cells and primary hepatocytes\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal interaction studies, functional copper-excretion assays, RNAi rescue, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"24909901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"ATP7B mediates vesicular sequestration of excess intracellular copper rather than direct translocation across the canalicular membrane; elevated copper stimulates ATP7B trafficking to pericanalicular vesicles in HepG2 cells; mutation of an endocytic retrieval signal causes constitutive vesicular localization; wild-type and mutant ATP7B cause CHO cells to accumulate copper in vesicles that subsequently undergo exocytosis.\",\n      \"method\": \"Immunofluorescence microscopy, copper accumulation assays in CHO cells expressing wild-type and endocytic-signal mutant ATP7B, site-directed mutagenesis\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization experiments with functional consequence, mutagenesis, and copper transport assays; multiple orthogonal methods in one study\",\n      \"pmids\": [\"16472602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Introduction of WND (ATP7B) cDNA via recombinant adenovirus into LEC rats (Wilson disease model) restored ATP7B protein to the Golgi apparatus and rescued synthesis of holoceruloplasmin (oxidase-active, copper-bound ceruloplasmin) in plasma, directly demonstrating that ATP7B functions in copper transport coupled with ceruloplasmin biosynthesis and that the Golgi is the functional site.\",\n      \"method\": \"Adenovirus-mediated gene delivery, immunofluorescence and subcellular fractionation, Western blot and plasma ceruloplasmin oxidase activity measurement in LEC rats\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo functional rescue with multiple biochemical readouts, replicated across multiple independent measurements in a well-established disease model\",\n      \"pmids\": [\"9430732\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The conserved CPC (Cys-Pro-Cys) motif in the membrane-spanning segment of ATP7B is essential for copper transport; mutation of CPC to SPS abolished ATP7B function in yeast complementation of ccc2 mutants. Five Wilson disease missense mutations in predicted membrane-spanning segments retained partial copper transport activity in yeast.\",\n      \"method\": \"Yeast complementation assay (ccc2 mutant rescue), site-directed mutagenesis of ATP7B cDNA\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro functional reconstitution (yeast complementation) with systematic mutagenesis; multiple variants tested, clear mechanistic conclusion\",\n      \"pmids\": [\"9837819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Wilson disease ATP7B variant proteins that retain copper transport activity in yeast (Asp765Asn, Leu776Val) showed mislocalization in CHO cells and impaired copper-dependent redistribution; the CPC→SPS mutant and Gly943Ser localized normally to the Golgi but could not redistribute in response to copper, indicating that copper-induced trafficking is a distinct functional requirement from catalytic copper transport.\",\n      \"method\": \"Yeast complementation assay, transient transfection of CHO cells, triple-label immunofluorescence microscopy\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assay combined with direct localization in mammalian cells; multiple variants systematically analyzed\",\n      \"pmids\": [\"10942420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"COMMD1 specifically interacts with the amino-terminal region of ATP7B independently of intracellular copper levels and ATOX1 expression. Four Wilson disease patient-derived N-terminal mutations significantly increased ATP7B binding to COMMD1, leading to mislocalization and increased degradation of ATP7B. COMMD1 markedly decreases the stability of newly synthesized ATP7B but does not affect copper-induced trafficking.\",\n      \"method\": \"GST pull-down, co-immunoprecipitation, immunofluorescence microscopy, site-directed mutagenesis, biosynthetic pulse-chase labeling\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pull-down and Co-IP with mutagenesis and pulse-chase; multiple orthogonal methods in single study\",\n      \"pmids\": [\"17919502\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Clusterin and COMMD1 independently interact with ATP7B and facilitate its degradation via distinct pathways: clusterin via the lysosomal pathway and COMMD1 via the proteasomal pathway. The clusterin–ATP7B interaction is enhanced by oxidative stress or ATP7B mutation; COMMD1–ATP7B interaction increases only with misfolding mutations. Endogenous ATP7B exists in a complex with both clusterin and COMMD1 simultaneously, but these interactions are neither competitive nor cooperative.\",\n      \"method\": \"Co-immunoprecipitation, overexpression and siRNA knockdown, Western blot for endogenous protein levels, lysosomal and proteasomal inhibitor experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal Co-IP, gain- and loss-of-function, pathway inhibitors; multiple orthogonal methods in single study\",\n      \"pmids\": [\"22130675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Protein kinase D (PKD) phosphorylates serine residues of ATP7B at the trans-Golgi network; this phosphorylation protects ATP7B from proteasome-mediated degradation and is required for its trafficking from the Golgi to cytosolic vesicles. Both PKD-mediated phosphorylation and subsequent trafficking are copper-dependent: mutations of critical copper-binding sites completely prevented both. Mutation of Ser-478/481/1121/1453 to Ala markedly reduced ATP7B trafficking.\",\n      \"method\": \"Microsomal phosphorylation assays with PKD inhibitor CID755673, Western blot, site-directed mutagenesis, confocal microscopy in COS-1 and HepG2 cells, proteasome inhibitor (MG132) experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro phosphorylation assay, pharmacological and genetic perturbation, mutagenesis with functional readout; multiple orthogonal methods\",\n      \"pmids\": [\"21189263\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Copper relay through the N-terminal metal-binding domains (MBDs) of ATP7B follows a defined mechanistic model: MBD1-3 form a regulatory unit; copper delivery via Atox1 to this unit and loading of MBD3 promotes release of inhibitory interactions; MBD4 can be mutated without large effect; intact copper sites in MBD5 or MBD6 are required for copper transport; only MBD6 can deliver copper to truncated ATP7B lacking all six MBDs, suggesting a specific docking role for MBD6.\",\n      \"method\": \"Yeast copper transport assay with strategic cysteine-to-serine mutations blocking individual MBD copper-binding sites in full-length and truncated ATP7B constructs\",\n      \"journal\": \"Metallomics : integrated biometal science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic in vivo functional reconstitution with multiple designed mutants; single lab but extensive mutagenesis series with clear mechanistic conclusions\",\n      \"pmids\": [\"31321400\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human ATP7B forms stable dimers in eukaryotic cells; the dimer interface is formed by conserved domains (not the N-terminal MBDs 1–4, which are unique to human ATP7B). Dimeric structure is retained during trafficking between intracellular compartments. A low-resolution 3D model by negative-stain EM of purified dimeric 1-4ΔMBD-7B provided the first structural insight into the overall architecture of a human Cu-ATPase.\",\n      \"method\": \"Co-immunoprecipitation of differentially tagged variants, purification of ATP7B after membrane solubilization, negative-stain electron microscopy, single-particle analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP with differentially tagged constructs plus low-resolution EM; single lab, two orthogonal methods\",\n      \"pmids\": [\"28842499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Cisplatin binds to ATP7B and stimulates catalytic phosphorylation (EC50 similar to copper), but unlike copper it does not induce trafficking of ATP7B in hepatoma cells and does not compete with copper in a transport assay. Deletion of the first four copper-binding sites of ATP7B abolishes cisplatin-induced phosphorylation; mutation of the first five sites does not. These data indicate that cisplatin interacts functionally with ATP7B but is not actively transported through the copper translocation pathway.\",\n      \"method\": \"ATPase phosphorylation assay, copper transport competition assay, confocal microscopy (trafficking), site-directed deletion mutagenesis in Huh7 hepatoma cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic assay with mutagenesis and functional trafficking readout; multiple orthogonal methods in single study\",\n      \"pmids\": [\"19141620\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Both ATP7A and ATP7B sequester platinum drugs (cisplatin, carboplatin, oxaliplatin) into vesicular compartments, reducing cytoplasmic platinum available to reach DNA. Fibroblasts engineered to express ATP7B showed increased platinum in isolated vesicles for all three drugs. Copper triggered ATP7A relocalization but platinum drugs did not, indicating the sequestration mechanism is distinct from the copper-stimulated trafficking response.\",\n      \"method\": \"Engineered cell lines (Menkes fibroblasts ± ATP7B or ATP7A expression), whole-cell and vesicle platinum accumulation assays, cytotoxicity assays, immunofluorescence\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays with engineered cell lines and vesicle fractionation; single study, two orthogonal readouts\",\n      \"pmids\": [\"15213293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"H1069Q-ATP7B is trapped in the endoplasmic reticulum rather than localizing to the trans-Golgi network in both human Wilson disease patient liver tissue (immunogold EM) and in HuH-7/HepG2 hepatoma cells. Truncated ATP7B mutants show diffuse cytoplasmic distribution distinct from TGN or ER, while most missense mutants distribute similarly to wild-type.\",\n      \"method\": \"Immunogold electron microscopy of patient liver biopsies, confocal microscopy of GFP-tagged ATP7B mutants in hepatoma cells\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct subcellular localization in patient tissue and cell lines; replicated across two independent systems (patient tissue + cell lines) for the key H1069Q mutant\",\n      \"pmids\": [\"12557139\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The toxic milk (tx) mutation in murine Wilson protein (Wnd) disrupts copper-induced relocalization of Wnd in CHO cells and abolishes Wnd-mediated copper resistance. With elevated copper, wild-type Wnd accumulates in large multivesicular structures resembling late endosomes, distinct from the post-Golgi destination of ATP7A/MNK, even when both proteins are in the same cell.\",\n      \"method\": \"Transient transfection of CHO cells, copper resistance assays, colocalization immunofluorescence, ultrastructural analysis (electron microscopy)\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional copper resistance assay plus ultrastructural localization; multiple methods in single study\",\n      \"pmids\": [\"11157799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In kidney, ATP7B does not traffic in response to elevated copper (unlike hepatic ATP7B and ATP7A), and therefore is unlikely to mediate copper export. Renal ATP7B is 2–3 kDa smaller than hepatic ATP7B, suggesting cell-specific processing; lack of trafficking is not due to absence of kinase-mediated phosphorylation or co-expression of ATP7A. Recombinant ATP7B expressed in renal cells traffics differently from in hepatic cells.\",\n      \"method\": \"Immunofluorescence microscopy, subcellular fractionation, Western blot, RT-PCR of ATP7B mRNA variants across cell types, comparison of endogenous renal vs. hepatic ATP7B\",\n      \"journal\": \"Traffic (Copenhagen, Denmark)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization with functional readout across cell types; single lab, multiple orthogonal approaches\",\n      \"pmids\": [\"19416479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"COMMD1 binds both ATP7B and phosphatidylinositol(4,5)-bisphosphate [PtdIns(4,5)P2]; COMMD1 modulates copper-responsive ATP7B trafficking through recruitment to PtdIns(4,5)P2 membranes. Decreased COMMD1 causes loss of ATP7B from lysosomes and TGN under high copper and leads to early endosome accumulation of ATP7B; excess COMMD1 also disrupts ATP7B trafficking. A COMMD1 mutant unable to bind PtdIns(4,5)P2 had little impact on ATP7B trafficking.\",\n      \"method\": \"Quantitative colocalization analysis by confocal microscopy, siRNA knockdown and overexpression of COMMD1, PtdIns(4,5)P2-binding mutant of COMMD1 in HepG2 cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative localization with gain- and loss-of-function and domain mutant; single lab\",\n      \"pmids\": [\"31515276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ATP7B and ATP7A reside on distinct TGN domains under limiting copper. In high copper, ATP7B traffics to the apical membrane via common recycling endosomes, apical sorting endosomes, and apical recycling endosomes (transcytotic route), while ATP7A traffics basolaterally. The AP-1A complex provides directionality and TGN retention for both Cu-ATPases; the AP-1B complex governs copper-independent trafficking of ATP7B to the apical domain specifically. Knockout of pan-AP-1 disrupts sorting of both ATPases.\",\n      \"method\": \"Polarized epithelial cell imaging (confocal microscopy), mass spectrometry identification of regulatory partners, AP-1A and AP-1B isoform-specific CRISPR knockouts, analysis of Wilson disease-causing ATP7B trafficking mutants\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — MS-based partner identification combined with isoform-specific KO and disease mutant analysis; multiple orthogonal methods in single study\",\n      \"pmids\": [\"38032054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Wilson disease mutations that cause protein misfolding result in reduced ATP7B expression (protein but not mRNA) and ER retention. Culturing cells at 30°C increases expression and normalizes localization of mutant ATP7B. Four distinct mutations retained residual copper export capacity. Pharmacological chaperones 4-phenylbutyrate (4-PBA) and curcumin partially restored protein expression of most ATP7B mutants.\",\n      \"method\": \"Western blot, immunofluorescence microscopy, copper export assays, temperature-rescue experiments, homology modeling, pharmacological chaperone treatment in transfected cell lines\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic analysis of multiple mutants with functional copper export assay, temperature rescue, and pharmacological correction; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19937698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ATP7B variants causing Wilson disease disrupt the protein's function through diverse mechanisms: some cause complete loss of catalytic and transport activity; others lose transport activity but retain phosphointermediate formation; yet others have partial activity losses. Transport-competent variants differ in stability and subcellular localization in mammalian cells.\",\n      \"method\": \"Baculovirus/Sf9 expression system, ATPase catalytic activity assay, 64Cu transport into vesicles, GFP-tagged protein localization by confocal microscopy in mammalian cells\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — reconstituted transport assay in vesicles with radiotracer, catalytic activity measurement, and localization; multiple orthogonal methods for 28 variants\",\n      \"pmids\": [\"22240481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP7B in intestinal enterocytes maintains a copper gradient along the duodenal crypt-villus axis; it buffers copper levels in the cytosol via rapid copper-dependent enlargement of ATP7B-containing vesicles and increased ATP7B levels. Loss of intestinal ATP7B (Atp7b-/- mice) causes reduced copper storage pools, accumulation of triglyceride-filled vesicles, mislocalization of apolipoprotein B, and loss of chylomicrons, linking ATP7B-mediated copper buffering to chylomicron assembly.\",\n      \"method\": \"Immunohistochemistry, X-ray fluorescence for copper distribution, electron microscopy, immunoblotting in Atp7b-/- mice; fluorescent confocal microscopy of primary 3D enteroids with copper treatment and chelation\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function mouse model with multiple tissue-level and organoid readouts plus direct localization experiments; multiple orthogonal methods\",\n      \"pmids\": [\"28958857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Copper-induced translocation of ATP7B from Golgi to dispersed vesicles is independent of Rab7-regulated endolysosomal trafficking and independent of COMMD1/Murr1: RNAi depletion of COMMD1 or Rab7 (or dominant-negative Rab7) did not impair ATP7B translocation; no colocalization of translocating ATP7B with COMMD1 or Rab7 markers was observed. COMMD1 acts at a later step in the copper excretion pathway.\",\n      \"method\": \"Confocal microscopy, siRNA knockdown of COMMD1 and Rab7, dominant-negative Rab7 expression in multiple non-hepatic cell lines\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — negative epistasis result established by RNAi in multiple cell lines; single lab, two approaches (siRNA + dominant negative)\",\n      \"pmids\": [\"18974300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Transcription factor EB (TFEB) directly binds to CLEAR (coordinated lysosomal expression and regulation) sites in the proximal promoter and first intron of ATP7B upon platinum exposure, driving ATP7B transcription in platinum-resistant ovarian cancer cells. Suppression of TFEB inhibits ATP7B expression and increases cisplatin toxicity in resistant cells.\",\n      \"method\": \"ChIP assay (TFEB binding to ATP7B CLEAR elements), luciferase reporter assays with ATP7B promoter fragments, TFEB siRNA knockdown, cisplatin sensitivity assays in IGROV-CP20 cells\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP plus reporter gene assay plus functional knockdown; single lab, two orthogonal methods confirming transcriptional regulation\",\n      \"pmids\": [\"35053335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MTF1 (metal regulatory transcription factor 1) specifically binds to the metal-responsive element MREe in the ATP7B promoter, and this interaction significantly increases ATP7B promoter-driven reporter gene expression, identifying MTF1 as a transcriptional regulator of ATP7B.\",\n      \"method\": \"Electrophoretic mobility shift assay (EMSA), MatInspector computational analysis followed by experimental EMSA validation, luciferase reporter assay\",\n      \"journal\": \"Annals of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — EMSA (direct protein-DNA binding) plus functional reporter assay; single lab, two orthogonal methods\",\n      \"pmids\": [\"31596515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The frequent H1069Q substitution promotes ATP7B interaction with HSP70, accelerating ER-associated degradation of the mutant protein and causing copper accumulation in hepatic cells. The HSP70 inhibitor domperidone (an FDA-approved drug) impairs HSP70–ATP7B-H1069Q interaction, recovering trafficking and function of the mutant protein.\",\n      \"method\": \"Proteomics (protein interaction landscape of H1069Q vs. wild-type ATP7B), HSP70 inhibitor experiments, copper accumulation assays, confocal microscopy of mutant ATP7B trafficking in hepatic cells\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — proteomic identification of interaction combined with functional pharmacological rescue and trafficking assays; multiple orthogonal methods\",\n      \"pmids\": [\"33288711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"ATP7B directly interacts with LC3B via a conserved LC3-interaction region (LIR3) at the C-terminal end of ATP7B; replacing the conserved hydrophobic residues W1452 and L1455 significantly reduced interaction. Autophagy induction enhances colocalization of ATP7B and LC3B on autophagosome membranes in HepG2 cells. ATP7B-deficient HepG2 cells show autophagy deficiency under elevated copper, complemented by re-expression of ATP7B.\",\n      \"method\": \"In silico LIR prediction, in vitro pulldown/binding assay (LIR3 peptide with LC3B), site-directed mutagenesis of LIR3, confocal colocalization in HepG2 cells, CRISPR ATP7B-knockout HepG2 cells with autophagy readouts\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro binding assay with mutagenesis plus cell-based colocalization and KO rescue; single lab, two orthogonal methods\",\n      \"pmids\": [\"34831341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ATP7B traffics from TGN to the bile canaliculus via basolateral sorting, endocytosis, and microtubule-mediated transcytosis through the subapical compartment; trafficking ATP7B is not incorporated into lysosomes. Copper addition does not cause relocalization of lysosomes or appearance of lysosome markers at the bile canaliculus, arguing against the lysosomal exocytosis model for biliary copper excretion.\",\n      \"method\": \"Live-cell and fixed confocal microscopy in polarized hepatocyte (WIF-B) cells, colocalization with organelle markers, copper treatment, lysosome marker tracking\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization in polarized cells with copper stimulation and organelle markers; single lab, contradicts some other studies; moderate confidence due to conflicting literature\",\n      \"pmids\": [\"27034138\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Loss of ATP7B in adrenal glands of Atp7b-/- mice causes reduced levels of dopamine beta-hydroxylase (DBH) protein and its products norepinephrine and epinephrine, even though Atp7b mRNA is not normally expressed in adrenal tissue. This indicates that copper-requiring enzymes in tissues remote from those expressing ATP7B are affected secondarily through systemic copper dysregulation.\",\n      \"method\": \"Western blot and catecholamine measurement in Atp7b-/- vs. wild-type mouse adrenal glands; RT-PCR to confirm absence of Atp7b mRNA in adrenal; copper level measurement\",\n      \"journal\": \"Neurochemical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function mouse model with specific biochemical phenotype; indirect/secondary effect demonstrated by absence of Atp7b mRNA; single lab\",\n      \"pmids\": [\"12718440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"During postnatal development, Atp7b is necessary for normal morphology and function of choroid plexus (ChPl); loss of Atp7b causes reorganization of ChPl cytoskeleton and cell-cell contacts, loss of Slc31a1 from the apical membrane, and decreased microvilli and cilia length and number. In ChPl lacking Atp7b, Atp7a is upregulated but remains intracellular, limiting copper transport into the brain and causing transient copper deficit with catecholamine imbalance and brain lipidome changes.\",\n      \"method\": \"Immunohistochemistry, Western blot, mass spectrometry (brain lipidome), RT-PCR, immunofluorescence microscopy in Atp7b-/- mouse choroid plexus\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function mouse model with direct morphological, biochemical, and lipidomic readouts; single lab, multiple phenotypic assays\",\n      \"pmids\": [\"36626371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Lymphoblast cell lines from Wilson disease patients homozygous for H1069Q and four other ATP7B mutations all demonstrated significantly decreased copper-stimulated ATPase activity, establishing that these mutations directly impair the enzymatic function of ATP7B.\",\n      \"method\": \"ATPase activity assay in patient-derived lymphoblast cell lines\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — enzymatic activity assay in patient-derived cells; single study, single method, but direct functional measurement across multiple mutations\",\n      \"pmids\": [\"9311736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Lack of evidence for ribosomal frameshifting in ATP7B mRNA decoding: apparent frameshifting detected with dual-luciferase polyprotein reporters was an artifact; when tested in a reporter system releasing reporters without polyprotein context, no frameshifting was detected above background. This refutes the proposed frameshifting mechanism for ATP7B expression.\",\n      \"method\": \"Dual luciferase reporter assays (two different reporter architectures), ribosome profiling data analysis, phylogenetic analysis of proposed frameshifting site\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — rigorous reporter assay comparison plus orthogonal ribosome profiling; single study but multiple complementary approaches clearly establishing a negative result\",\n      \"pmids\": [\"36115342\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"ATP7B is a P1B-type copper-transporting ATPase that uses ATP hydrolysis to translocate Cu+ across membranes via a stepwise pathway through transmembrane sulfur-containing ligands, regulated by its six N-terminal metal-binding domains (MBDs) where MBD6 delivers copper to the transmembrane entry site and MBD1-3 form an inhibitory regulatory unit; in hepatocytes it resides in the trans-Golgi network under basal conditions (delivering copper for ceruloplasmin biosynthesis), and upon copper elevation undergoes AP-1-dependent trafficking to lysosomes and/or apical vesicles via a transcytotic route, enabling lysosomal exocytosis and biliary copper excretion through interaction with dynactin p62; copper-dependent serine phosphorylation by protein kinase D stabilizes ATP7B and licenses this trafficking; protein stability is controlled by COMMD1 (proteasomal) and clusterin (lysosomal) degradation pathways, and the H1069Q disease mutant is specifically captured by HSP70 for ER-associated degradation; in intestinal enterocytes ATP7B buffers copper to support chylomicron assembly, and in the developing brain choroid plexus it maintains copper homeostasis necessary for normal brain copper delivery.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"ATP7B is a P1B-type copper-transporting ATPase that couples ATP hydrolysis to the translocation of copper across membranes and is the central effector of cellular and systemic copper homeostasis [#0, #20]. Catalytic copper transport requires the conserved transmembrane CPC motif and a network of sulfur-containing transmembrane ligands that define a stepwise translocation pathway, while six N-terminal metal-binding domains (MBDs) regulate the enzyme: MBD1\\u20133 form a regulatory unit relieved by Atox1-mediated copper delivery, and MBD6 docks at the cytoplasmic copper entry site to deliver copper to the transmembrane domain [#1, #5, #10]. Under basal copper, ATP7B resides in the trans-Golgi network where it supplies copper for holoceruloplasmin biosynthesis [#4]; upon copper elevation it undergoes a distinct, copper-dependent trafficking response \\u2014 mechanistically separable from catalytic transport \\u2014 to peripheral vesicles, lysosomes, and the apical/canalicular pole, enabling sequestration and excretion of excess copper into bile, with directionality conferred by AP-1 sorting complexes and lysosomal translocation aided by the dynactin subunit p62 [#2, #3, #6, #18]. This trafficking is licensed by copper-dependent serine phosphorylation by protein kinase D, which also stabilizes ATP7B against proteasomal degradation [#9], and ATP7B abundance is further controlled by COMMD1 (proteasomal) and clusterin (lysosomal) degradation routes that act on misfolded or oxidatively stressed protein [#7, #8]. Beyond the liver, ATP7B buffers cytosolic copper in intestinal enterocytes to support chylomicron assembly and apolipoprotein B localization, and maintains choroid plexus copper homeostasis required for normal brain copper delivery during development [#21, #29]. ATP7B is the gene mutated in Wilson disease, and characterized mutations impair the protein through diverse mechanisms including loss of catalytic/transport activity, defective copper-induced trafficking, and misfolding with ER retention and accelerated degradation \\u2014 the frequent H1069Q variant being trapped in the ER and captured by HSP70 for ER-associated degradation [#14, #20, #25].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing that Wilson disease mutations directly impair ATP7B enzymatic function answered whether disease arises from loss of the protein's catalytic activity.\",\n      \"evidence\": \"Copper-stimulated ATPase activity assays in patient-derived lymphoblast lines carrying H1069Q and four other mutations\",\n      \"pmids\": [\"9311736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not resolve which step of the catalytic cycle is impaired\", \"Patient cells may carry confounding genetic background\", \"No distinction between catalytic vs. trafficking defects\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"In vivo rescue and yeast complementation established that ATP7B functions in copper transport coupled to ceruloplasmin biosynthesis at the Golgi and that the transmembrane CPC motif is essential for transport.\",\n      \"evidence\": \"Adenoviral WND cDNA delivery into LEC rats restoring Golgi ATP7B and holoceruloplasmin; yeast ccc2 complementation with CPC\\u2192SPS mutagenesis\",\n      \"pmids\": [\"9430732\", \"9837819\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the transmembrane copper coordination geometry\", \"Mechanism of copper handoff to ceruloplasmin not resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Separating trafficking-competent from transport-competent mutants established that copper-induced redistribution is a distinct functional requirement from catalytic copper transport.\",\n      \"evidence\": \"Yeast complementation combined with copper-stimulated redistribution imaging of Wilson disease variants in CHO cells\",\n      \"pmids\": [\"10942420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking signals/machinery not identified\", \"Did not address tissue-specific trafficking differences\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The toxic milk mutant model showed copper-induced relocalization is required for copper resistance and that ATP7B targets a distinct late-endosomal/multivesicular destination separate from ATP7A.\",\n      \"evidence\": \"Transfection of CHO cells with mutant Wnd, copper resistance assays, and ultrastructural colocalization\",\n      \"pmids\": [\"11157799\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of distinct destination unresolved\", \"Late endosome identity not definitively marked\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Localizing H1069Q to the ER and documenting secondary catecholamine enzyme deficits clarified that the most common mutation causes ER retention and that systemic copper dysregulation affects copper enzymes in non-expressing tissues.\",\n      \"evidence\": \"Immunogold EM of patient liver plus GFP-mutant imaging; Western blot/catecholamine measurement in Atp7b-/- adrenal glands\",\n      \"pmids\": [\"12557139\", \"12718440\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"ER quality-control machinery acting on H1069Q not yet identified\", \"Adrenal effect is secondary/indirect, not a direct ATP7B function\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Demonstrating vesicular copper sequestration and exocytosis refined the excretion model away from direct canalicular membrane translocation.\",\n      \"evidence\": \"Immunofluorescence and copper accumulation assays in HepG2 and CHO cells with an endocytic-signal mutant\",\n      \"pmids\": [\"16472602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the exocytic vesicle compartment not fully defined\", \"Endocytic retrieval machinery not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying COMMD1 binding to the N-terminus established a copper-independent control of ATP7B stability distinct from its trafficking.\",\n      \"evidence\": \"GST pull-down, Co-IP, pulse-chase, and mutagenesis of N-terminal Wilson disease variants\",\n      \"pmids\": [\"17919502\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degradation pathway used by COMMD1 not specified in this study\", \"How N-terminal mutations enhance COMMD1 binding structurally unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Epistasis testing placed copper-induced ATP7B translocation upstream of and independent from COMMD1- and Rab7-regulated endolysosomal trafficking.\",\n      \"evidence\": \"siRNA and dominant-negative Rab7 with confocal colocalization in multiple non-hepatic cell lines\",\n      \"pmids\": [\"18974300\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Negative result; non-hepatic cells may differ from hepatocytes\", \"Exact step where COMMD1 acts not pinpointed here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Catalytic-cycle and pharmacological-chaperone studies dissected the spectrum of mutant defects and showed cisplatin engages ATP7B catalytically but is not transported through the copper pathway.\",\n      \"evidence\": \"Phosphorylation/transport competition assays with deletion mutants in Huh7 cells; copper export, temperature-rescue and 4-PBA/curcumin treatment of misfolding mutants; cell-type comparison of renal vs. hepatic trafficking\",\n      \"pmids\": [\"19141620\", \"19937698\", \"19416479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why cisplatin uncouples phosphorylation from trafficking unresolved\", \"Tissue-specific processing basis for renal non-trafficking not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying PKD phosphorylation explained how copper licenses both ATP7B stability and Golgi-to-vesicle trafficking.\",\n      \"evidence\": \"Microsomal phosphorylation assays with PKD inhibitor, serine-to-alanine mutagenesis, and trafficking imaging in COS-1/HepG2 cells\",\n      \"pmids\": [\"21189263\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How copper binding activates PKD toward ATP7B unclear\", \"Phosphatase counteracting this modification not identified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Resolving two parallel degradation routes (clusterin/lysosomal, COMMD1/proteasomal) defined non-redundant quality-control pathways governing ATP7B abundance.\",\n      \"evidence\": \"Reciprocal Co-IP, knockdown/overexpression, and lysosomal/proteasomal inhibitor experiments on endogenous ATP7B\",\n      \"pmids\": [\"22130675\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals selecting one route vs. the other not defined\", \"E3 ligase mediating COMMD1-linked proteasomal degradation unidentified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Systematic reconstitution of 28 disease variants categorized mutations into catalytic, transport, phosphointermediate, and stability/localization defect classes.\",\n      \"evidence\": \"Baculovirus/Sf9 ATPase and 64Cu vesicular transport assays with GFP-localization in mammalian cells\",\n      \"pmids\": [\"22240481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In-cell trafficking behavior of all variants not exhaustively mapped\", \"Genotype-phenotype correlation to clinical severity not established here\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linking ATP7B to lysosomal copper import and dynactin-p62-driven lysosomal exocytosis provided a mechanism for biliary copper excretion.\",\n      \"evidence\": \"Live-cell imaging, ATP7B\\u2013p62/dynactin Co-IP, siRNA, and copper excretion assays in HepG2 and primary hepatocytes\",\n      \"pmids\": [\"24909901\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Reconciling lysosomal exocytosis with transcytotic models unresolved\", \"How copper is released across the canalicular membrane not defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating an intestinal copper-buffering role connected ATP7B to chylomicron assembly, and a polarized-hepatocyte study challenged the lysosomal exocytosis model in favor of microtubule-mediated transcytosis.\",\n      \"evidence\": \"X-ray fluorescence, EM, and enteroid imaging in Atp7b-/- mice; live-cell confocal organelle-marker tracking in polarized WIF-B cells\",\n      \"pmids\": [\"28958857\", \"27034138\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Conflicting excretion routes (lysosomal vs. transcytotic) not reconciled\", \"Mechanistic link between copper buffering and apoB localization incomplete\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showing ATP7B forms stable dimers retained during trafficking provided the first architectural view of a human Cu-ATPase.\",\n      \"evidence\": \"Co-IP of differentially tagged variants and negative-stain EM of purified dimeric construct\",\n      \"pmids\": [\"28842499\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role of dimerization in transport/trafficking unknown\", \"Low-resolution model; high-resolution dimer interface not defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defining the MBD copper-relay hierarchy and COMMD1\\u2013PtdIns(4,5)P2 coupling clarified intramolecular regulation and membrane-recruitment control of trafficking, and identified MTF1 as a metal-responsive transcriptional regulator.\",\n      \"evidence\": \"Yeast transport assays with cysteine-to-serine MBD mutants; quantitative colocalization with COMMD1 PtdIns(4,5)P2-binding mutant in HepG2 cells; EMSA and reporter assays for MTF1\",\n      \"pmids\": [\"31321400\", \"31515276\", \"31596515\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis of MBD1\\u20133 inhibition not directly visualized here\", \"How COMMD1 lipid binding directs ATP7B at specific membranes incomplete\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identifying HSP70 capture of H1069Q and its pharmacological reversal defined a druggable basis for the most common Wilson disease defect.\",\n      \"evidence\": \"Proteomic interaction profiling, HSP70 inhibitor (domperidone) treatment, and trafficking/copper accumulation assays in hepatic cells\",\n      \"pmids\": [\"33288711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HSP70 targeting generalizes to other misfolding mutants unclear\", \"In vivo efficacy of HSP70 inhibition not established here\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying an LC3-interaction region linked ATP7B directly to autophagy regulation under copper stress.\",\n      \"evidence\": \"In vitro LIR3 peptide binding with mutagenesis and colocalization/KO-rescue autophagy readouts in HepG2 cells\",\n      \"pmids\": [\"34831341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding; in vitro binding not confirmed for full-length protein in vivo\", \"Physiological consequence of ATP7B\\u2013LC3B interaction incompletely defined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cryo-EM of the E2-Pi state and a rigorous negative result on frameshifting clarified, respectively, the transmembrane copper pathway/regulation and that ATP7B is decoded without ribosomal frameshifting.\",\n      \"evidence\": \"Cryo-EM of frog ATP7B; dual-luciferase reporter comparison plus ribosome profiling analysis for frameshifting\",\n      \"pmids\": [\"35245129\", \"36115342\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Copper-bound and trafficking-competent conformations not captured in E2-Pi state\", \"Functional asymmetry of dimer not addressed by monomeric structure\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human E1-state cryo-EM, AP-1-dependent polarized sorting, and the choroid plexus phenotype together resolved MBD6 docking at the copper entry site, the apical transcytotic route directed by AP-1, and a developmental brain copper-delivery role.\",\n      \"evidence\": \"Cryo-EM of human ATP7B in three states; polarized-cell imaging with AP-1A/AP-1B CRISPR KO and MS partner ID; Atp7b-/- choroid plexus IHC, lipidomics, and immunofluorescence\",\n      \"pmids\": [\"37074913\", \"38032054\", \"36626371\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full copper-translocation cycle intermediates still incompletely resolved\", \"How AP-1B isoform selectivity is achieved mechanistically unclear\", \"Reconciliation of apical transcytotic vs. lysosomal excretion routes still open\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the conflicting models of biliary copper excretion (lysosomal exocytosis vs. microtubule-mediated transcytosis) are reconciled, and how copper is ultimately released across the canalicular membrane, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model integrating lysosomal and transcytotic excretion routes\", \"Mechanism of final copper release into bile undefined\", \"Tissue-specific trafficking regulation across liver, intestine, kidney, and brain not mechanistically unified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140657\", \"supporting_discovery_ids\": [0, 1, 5, 20]},\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [3, 4, 5, 10, 20]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [12, 20, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [4, 14, 9]},\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [3, 15, 21]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [14, 19, 25]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [18]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [17, 18]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [4, 5, 20, 3]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [2, 18, 3]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [4, 21, 28]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [14, 25, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7, 8, 25]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"COMMD1\", \"ATOX1\", \"CLU\", \"DCTN4\", \"HSPA1A\", \"MAP1LC3B\", \"PRKD1\", \"TFEB\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}